IT – Genium INET 4.1.0215 Project Update (53/16) This

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IT – Genium INET 4.1.0215 Project Update (53/16)

This message contains important information regarding the Genium INET upgrade on November 19 th to version 4.1.0215 which includes new functionalities and enhancements going live November 21 st 2016.

The following changes, enhancements and improved functionalities will be introduced for Nasdaq Equity Derivatives, Fixed Income and Commodities in Genium INET 4.1.0215.

  • Circuit Breakers (Equity Derivatives) API
  • Stressed Market Conditions (Equity Derivatives) API, ITCH
  • Updates to Pre-Trade controls (Equity Derivatives)
  • Accrued Coupon information for OTC Swaps (Fixed Income) API
  • Modified API for Netting on Account Level for OTC Rates (Fixed Income) API
  • Nordic Electricity options on Futures (Commodities)
  • One additional week listed for Renewable Futures (Commodities)
  • Enhanced CMS Securities safekeeping fees (All Asset Classes) API
  • KID field on Instrument Type and Instrument Class (All Asset Classes) API

Final technical specifications are now available on the Enhancement website.  

The planned project timeline for Genium INET 4.1.0215

23 September Final technical specifications available
3 October Release of initial Nasdaq front-ends
5 October External test system 3 availability
13 October External test system 4 availability
21 October Go-live candidates of Nasdaq front-ends
4 November External test system 1 availability
19 November Upgrade of Genium INET to version 4.1.0215
21 November First trading and clearing day for Equity Derivatives, Fixed Income and Commodities on Genium INET 4.1.0215

Please visit our website where you will find technical specifications and information regarding technical impact. 

http://www.nasdaqomx.com/transactions/technic...t-4.1.0215  

For questions or comments, please contact:

Technical Relations

Anders Bergström anders.bergstrom@nasdaq.com +46 8 405 7364

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading